Ignite Creation Date:
2024-05-06 @ 2:02 PM
Last Modification Date:
2024-10-26 @ 1:24 PM
Study NCT ID:
NCT04198896
Status:
COMPLETED
Last Update Posted:
2019-12-18
First Post:
2019-12-08
Brief Title:
The Sakakibara Health Integrative Profile of Atherosclerotic-Carcinogenesis Hypothesis SHIP-AC
Sponsor:
Sakakibara Heart Institute
Organization:
Sakakibara Heart Institute
Study Overview
Official Title:
Clinical Aspects of Atherosclerotic-Carcinogenesis Hypothesis
Status:
COMPLETED
Status Verified Date:
2019-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SHIP-AC
Brief Summary:
As previously reported IJC Heart Vasculature 2017 17 11 our epidemiological analysis showing high incidence of cancers in patients with atherosclerotic cardiovascular diseases as compared with those with non-atherosclerotic cardiovascular diseases may imply a clinical possibility of a role of atherosclerosis in cancer developments In the present study to address our hypothesis that cancer developments may come with a strength of atherosclerosis we traced an incidence of cancers in a total of 8856 patients with coronary artery diseases CAD for a median follow-up of 1095 days interquartile range 719-1469 days using the Sakakibara Health Integrative Profile SHIP database
Detailed Description:
In accordance with a presence or absence of poly-arterial diseases such as aortic andor peripheral artery diseases as an indicator of a strength of atherosclerosis an incidence of cancers and all-cause death in two cohorts of 8140 patients with CAD-only and 716 with CAD with poly-arterial diseases were evaluated to track an incidence of cancers and ali-cause mortality during median follou-up periods of 3 to 4 years
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None